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Background: Globally, cardiovascular disease (CVD) is the leading cause of death 
among women. In China, the burden of CVD is increasing at an alarming rate, yet the 
burden of this disease is underestimated and this is reflected in primary, secondary 
and tertiary prevention issues.  
 
Aim: This paper seeks to document the issue of the increased rate of CVD among 
Chinese women, describe etiological factors and describe potential strategies to 
decrease the burden of disease. 
 
Method: The Medline, CINAHL, Ovid, Science Direct and Government Reports were 
searched using the key words “heart disease”, “cardiovascular”, “ischemic heart 
disease”, “ coronary”, “women”, and “Chin (China, Chinese)*”. Articles were 
selected if they described epidemiological factors and/or interventions to address heart 
disease in Chinese women. 
 
Findings: Rapid industrialization and urbanization in China have extended the life 
expectancy of the population, particularly among women.  Social, political and 
economic factors have caused lifestyle changes that have a direct bearing on health- 
related issues. Compared to previous epidemiological trends, heart disease has 
become the most common cause of death among Chinese women and the second most 
common among men. Paradoxically, prevention and management strategies are sparse 
in relation to the high prevalence.  A number of modifiable risk factors have been 
identified as major contributors of CVD and should be a focus of primary, secondary 
and tertiary prevention. 
 
Conclusion: CVD is already a leading cause of death and disability among Chinese 
women. The high prevalence of risk factors and low rate of awareness, treatment, and 
control, signal an urgent need for focusing on this issue in Chinese women. Strategies 
on an individual, community and government level are recommended. Involving 
Chinese nurses in these strategies is essential. 
 
 






Introduction   
During the past decades, cardiovascular disease (CVD) has become a major cause of 
morbidity and mortality in women worldwide 1. Of the total 16.5 million CVD deaths 
annually, 8.6 million are in women2. Death from heart attack and stroke are 
responsible for twice as many deaths in women as all cancers combined2. 
 
Although CVD risk is perceived to be low in Chinese women, the burden of disease is 
increasing rapidly.  Heart disease and cerebrovascular disease are two of three 
leading causes of death, and account for around 40% of deaths from all causes since 
19903-4.  During the mid 1990s, 20% of the 2.2 million middle-aged women 
worldwide who died of heart disease and stroke were Chinese5. According to 
American Heart Association report, the stroke incidence rates in Chinese women were 
152 and 147 per 100,000 people in urban and rural areas respectively, only less than 
Russian Federation at 220 and Romania at 166 per 100,000 population6. It is likely 
that Chinese women will continue to experience disproportionately high mortality 
from CVD. According to the WHO report, by 2040, Chinese women are projected to 
be 49.5% of the population.  Even if death rates remain constant, Chinese women 
will represent 54.6% of CVD deaths 2. 
 
It is well documented that CVD is preventable among both men and women7. The 
identification of risk factors and effective control strategies have contributed to the 
fall in CVD mortality rates that has been observed in most industrialized countries 
including the United States of America, Finland, and Australia8. Globally, the risk of 
CVD is underestimated, contributing to the rise in disease burden.  Many women are 
unaware that CVD is the principal cause of death of their gender. More worrisome, 
there is an apparent lack of awareness of CVD prevalence in women among 
healthcare professionals1.  
 
In parallel with other developing countries, Chinese authorities primarily focus on 
communicable diseases rather than chronic diseases, such as CVD9. This paper aims 
to document cause and risk factors responsible for the high prevalence of CVD in 
Chinese women and to recommend a multifaceted strategy to combat these risks. 
Finally, implications for Chinese clinical and research nurses are discussed. 
 
Social change and epidemiological transition 
China is the largest developing country in the world and is facing rapid economic 
development fuelled by social and economic change. Between 1985 and 1999, the 
gross domestic product (GDP) per capita rose by 8% per year, the second fastest 
increase globally10.  In 2005, China’s economic growth rate was 9.9%, its GDP 
reached US$2.26 trillion, and China became the 4th largest economy in the world11. As 
a result of this rapid socioeconomic development, the average life expectancy and 
health status have changed dramatically. For Chinese women, life expectancy has 
increased 39.8 years to 73 years of age from 1949 to 2001 owing to the decline in 
childbirth mortality, malnutrition, and infectious disease 4. Table 1 shows the trend of 
life expectancy in China from before the founding of People’s Republic of China 
through to 2000. The increasing longevity provides longer periods of exposure to the 
risk factors of CVD, resulting in a greater probability of clinically manifested CVD 
events12. CVD risk increases after menopause, which may be related to the substantial 
metabolic changes that occur as women transition from pre- to post-menopause13. 
 
Table 2 illustrates the health transition trajectory in China. In 1957, diseases of the 
respiratory system, acute infectious diseases, and tuberculosis were the leading causes 
of mortality, accounting for 16.9%, 7.9%, and 7.5% of deaths, respectively. 
Meanwhile, heart disease and cerebrovascular disease were between diseases and 
ranked fifth and sixth by contributing to 6.6% and 5.5% of total deaths, respectively14. 
Table 3 shows that in 2005, chronic diseases were the main cause of death in women, 
as opposed to communicable diseases.  Among them, CVD accounts for 41.9% and 
35.7% of deaths in urban and rural areas respectively.  
-----------------Insert Table 1 ------------ 
----------------Insert Table 2 ------------ 
-----------------Insert Table 3 ------------ 
 
Change of lifestyle 
The results of the Sino-MONICA studies show significant variations of CVD rates 
and risk factor levels between populations, which are resultant of lifestyle changes 
and unrelated to genetics15.  The studies also show the Chinese population has a 
lower genetic predisposition for CVD compared with other populations16-17. Rapid 
economic development, industrialization and urbanization, and lifestyle patterns have 
changed dramatically. More and more women adopt western lifestyles, including a 
high intake of dietary fat, less physical activity, smoking, and drinking. For example, 
Table 4 shows the overall increases in fat intake and consumption of animal protein 
and the decrease in consumption of cereals. 
-----------------Insert Table 4 here------------ 
 
Prevalence of CVD risk factors 
The increasing rate of CVD is not surprising given the increasingly high prevalence of 
CVD risk factors in Chinese women. Gu et al18 demonstrated that between 12-35% of 
Chinese women aged 35 to 74 years had from one to more than three major CVD risk 
factors including dyslipidemia, hypertension, diabetes , cigarette smoking, and being 
overweight. The age-standardized prevalence of >1, >2, and >3 CVD risk factors was 
higher in American women than their Chinese counterparts, 93.1%, 73%, and 35.9% 
compared with 71.3%, 59.1% and 12.2%, respectively19.  
 
Hypertension 
Hypertension plays a major etiologic role in the development of cerebrovascular 
disease, ischemic heart disease, and cardiac and renal failure20. A longitudinal study 
undertaken by Fang et al showed that hypertension was significantly related to risk of 
stroke in China21.  The prevalence and absolute numbers of hypertension have 
increased dramatically during the past several decades. The estimated number of 
hypertension cases among Chinese adults has increased from 30 million in 1960 to 94 
million in 1990 and 160 million at present22-23.  Figure 1 shows the increased 
prevalence of hypertension in Chinese women.  
 
Given the high incidence of hypertension, compared with western countries, the 
burden of stroke is much more common than coronary heart disease in China. Each 
year, 1.3 million Chinese people have a first stroke, four times the incidence of acute 
myocardial infarction24.  Despite this statistic, studies indicate that rates of 
awareness, treatment, and control of hypertension were unacceptably low22, 25. The 
study undertaken by Antikainen et al showed at the 160/95 mmHg threshold, the 
highest proportion (92%) of controlled hypertensive female individuals were in New 
Zealand, while 70% were in Stanford, California, U.S.A, and 38% in Beijing, China. 
When the threshold of hypertension was lowered to 140/90 mmHg, 63% of female 
hypertension patients were adequately controlled in Ghent, Belgium, while 52% were 
in Stanford, and only 21% were in Beijing26.  




It is well known that the higher the level of serum cholesterol, the higher the risk of 
CVD in both men and women. Dyslipidemia is a modifiable risk factor that has a 
substantial impact on the outcomes of patients with CVD, especially for women27. 
Decreasing total cholesterol levels by 10% can decrease the incidence of coronary 
heart disease by as much as 30%28.  Ford et al found the total cholesterol 
concentration in American women decreased slightly from 5.35 mmol/L in 1988 
through 1994 to 5.29 mmol/L in 1999 through 200029.  While Critchley et al’s 
Beijing survey showed that total cholesterol in women aged 55 to 64 years increased 
from 4.7 to 5.9 mmol/L between 1984 and 1999, an absolute increase of 1.19 
mmol/L30.  However, researchers found that among those who had a total cholesterol 
200 mg/dl or who were on cholesterol-lowing medications, the proportion of women 
who were aware, treated, and controlled was 3.4%, 1.9%, and 1.5% respectively, 




Diabetes is a powerful risk factor in women, regardless of age32. The risk of 
cardiovascular events in diabetic women is higher than that of both diabetic men and 
non-diabetic women33.  The risk of myocardial infarction (MI) is twice as high in 
women with diabetes as in non-diabetic women of the same age32.  The incidence of 
CVD in diabetic women is two to six times that of non-diabetic women, whereas the 
incidence is only doubled in diabetic men33.  This difference may be due to a 
particularly deleterious effect of diabetes on lipids and blood pressure in women34. 
Figure 2 shows the global epidemic of diabetes. The top three countries are India with 
a growth form 31.7 million to 91.4 million, China, from 20.8 million 42.3 million, and 
U.S.A from 17.7million to 30.3 million diabetic people in 2000 to 203035. 
-----------------Insert Figure 2 here------------ 
 
Cigarette Smoking 
Current smokers are those people using tobacco products at the time of a survey. 
Passive smokers are those exposed to another’s tobacco smoke for at least 15 minutes 
daily on more than 1 day per week. There are variable mechanisms by which tobacco 
smoking impacts the cardiovascular system, such as producing acute increases in 
heart and blood pressure and platelet aggregation, causing endothelial cell damage, 
and accelerating atherosclerosis36. 
 
China is the world’s largest producer and consumer of tobacco products and bears a 
large proportion of the global burden of smoking-related disease37. Unlike the 25% of 
British women who are smokers38, their Chinese counterparts contribute to a small 
portion of China’s 350 million smokers. However more than 60% of female 
non-smokers are exposed to environmental tobacco smoke (ETS) in their homes, 
workplaces and in public places39. There is a debate regarding the causal role of 
passive smoking in heart disease40.  Surveys on the relationship between passive 
smoking and CVD show that ETS is a risk factor for an elevated prevalence of CVD 
in Chinese women41-42.  In addition to the 50 million people who want to quit 
smoking, there is a growing smoking epidemic among young people39. Therefore, 
enhanced knowledge of the health risks of smoking and trials of controlled measures 
designed to suit Chinese cultural and economic conditions are needed. 
 
Physical inactivity 
Physical inactivity not only doubles the risk of developing heart disease and 
increasing the risk of hypertension by 30%, but also doubles the risk of dying from 
CVD and stroke43.  Globally, both in western and eastern countries, more women 
than men were physically inactive4.  A study on Chinese women showed that 
physical activity is related to serum lipid concentrations and insulin resistance, the 
grade of energy expenditure from exercise being positively related to antioxidant 
capacity and insulin sensitivity45.  In contrast to Chinese people’s traditionally high 
level of physical activity, study results from the international collaborative study of 
CVD in Asia showed that in rural and urban China, 78.1% and 21.8% of residents, 
respectively, were physically active; 75.8% and 16.5%, respectively, participated in 
work-related activity; and 28.9% and 7.9% respectively, participated in leisure-time 
physical activity46. In both rural and urban settings, women were less likely to be 
physical active and to participate in work-related and leisure-time physical activity 
than men46.  
 
Obesity 
Obesity is well recognized as a major risk factor for CVD both in men and women 
and about a fifth of the one billion overweight or obese people in the world are 
Chinese47. The surveys conducted in large cities such as Beijing indicate 35.2% of 
men and 39.5% of women are overweight48. China was once considered to have one 
of the leanest populations and it is true that compared with their American 
counterparts, Chinese women have a relatively low average BMI and waist 
circumference (WC). However, studies have suggested that WHO/National Heart 
Lung and Blood Institute (NHLBI) overweight and central adiposity guidelines based 
on Western populations are not appropriate for Asian populations.  Rather, the cutoff 
points recommended by International Obesity Task Force are more appropriate49.  
The researchers indicate that a BMI of 24 and WC of 80 centimeters for Chinese 
women are more appropriate cutoffs for the designation of weight and central 
adiposity50.  There is a need for further investigation into specific BMI and WC 
cutoffs and their relationship to CVD in Chinese women. 
 
Contributing risk factors 
It has been shown that socioeconomic status, including education, occupation, income 
and marital status is inversely associated with cardiovascular mortality and 
morbidity51. Researchers found these associations were more consistent among 
women than men in China52. However, a seven year follow-up study revealed the 
opposite trend in that the deterioration of CVD risk factors mainly occurred in the 
most educated people53. Also, parental or sibling CVD is a potential predictor of CVD.  
If a parent has CVD, their child has twice the risk, but if a sibling has CVD, this risk 
may in fact be even greater for an individual54, 55. 
 
Individual approach 
Significant advances in our knowledge of interventions to prevent CVD have 
occurred since publication of the first female-specific recommendations for 
preventive cardiology in 199932. Figure 3 illustrates a multifaceted strategy from 
individual, community, and relative authorities. Given tobacco smoking, physical 
inactivity, unhealthy diet, and accompanying obesity are responsible for at least 75% 
of CVD56, the prevention of CVD traditionally depends on control of risk factors 
among individuals as a major component of any strategy. 
 
Smoking and Physical activity 
There is good evidence demonstrating cardiovascular hazards of smoking and passive 
smoking40-41, as well as the prompt benefit that occurs with smoking cessation 
regardless of former smoking status and smoking related disease or symptoms57. 
Women should be consistently encouraged not to smoke and to avoid environmental 
tobacco. WHO and AHA recommend women to accumulate a minimum of 30 minutes 
of moderate-intensive physical activity on most or preferably all days of the week7. 
 
Diet 
The traditional Chinese diet used to be rich in carbohydrates (about 60% of energy 
intake), fruits, and vegetables. A woman’s diet plays a key role in her cardiovascular 
health. In the evidence-based guidelines of CVD prevention in women, 4 of the 8 
clinical recommendations for lifestyle modifications were diet-related7. In terms of 
cardiovascular-healthy diets, essential aspects of good nutrition for women include 
diets rich in fiber, whole grains, fresh fruits, vegetables, fish, nuts, antioxidants, 
minerals, vegetable protein, marine and plant omega-3 fatty acids and vitamins of the 
B group58. Two large cohort studies in Shanghai showed that soy and soy constituents 
were significantly and inversely associated with the risk of coronary heart disease and 
hypertension among Chinese women41, 59. 
 
Drug therapy 
Medication and treatment adherence is a critical factor in cardiovascular disease, yet, 
cultural factors often impede concordance with treatment recommendations60.  
Implementation of AHA western-based guidelines7, 32, 61-63 may benefit Chinese 
women but may differ culturally, medically, and economically.  In light of the 
paucity of research, there is a heightened need to further investigations focusing on 
locally tailored preventive measures and treatment guidelines for CVD in Chinese 
women. The high usage of Traditional Chinese Medicine underscores the importance 
of consideration of drug interactions and tailoring of advice and information that is 
culturally appropriate and acceptable64.   
 
Community Approaches 
Studies show that community-based intervention plays an important role in both 
primary and secondary prevention of CVD. The community intervention conducted in 
Guzhen reveals that community-based comprehensive prevention of cardiovascular 
disease improves the awareness, attitudes, and behaviors, in community groups and 
reduces morbidity and mortality of cerebral apoplexy65.  Similar findings resulted 
from a nine-year community-based intervention in China’s three most modern cities, 
Beijing, Shanghai, and Changsha, where stroke is highly prevalent66.  Community 
health providers should focus on educating women about initiating and maintaining a 
healthy lifestyle as a cornerstone of primary and secondary prevention. 
 
Policy and regulatory strategies  
Chronic diseases account for an estimated 80% of deaths and 70% of 
disability-adjusted life-years lost in China67.  Rates of death from them in 
middle-aged people are higher in China than in some high income countries68. The 
decision makers of health policy and guidelines must confront these major challenges 
and take actions to avert the increasing burden of CVD in Chinese women.   
 
As many western countries have banned smoking in all workplaces and public areas, 
it should also be introduced to China as early as possible. Labeling of ingredients in 
manufactured foods should be mandatory. The food industry should provide and 
consumers could select foods that are low in fat, sugar, and salt.  Responsible 
advertising and media depictions of diet and other lifestyle factors should be 
mandated. 
 
Most Chinese patients self-fund their own medical treatment.  Chinese women, who 
are conditioned to defer their own needs to those of their family’s, are often reluctant 
to seek out care for themselves unless an emergency arises. One positive reform 
within the health system would be to give greater priority to the prevention and 
control of CVD in women, making the drugs and equipment for primary and 
secondary prevention accessible and affordable, especially in the rural areas.  
 
Further, in light of the paucity of Chinese women-specific studies, there is an urgent 
call for long-term domestic and international collaborative research and intervention 
programs. For example, by studying the knowledge and attitude of CVD among 
health providers, the public, and women themselves, we can identify specific 
knowledge deficiencies and vulnerable populations. Launching a campaign, like 
American Heart Association’s “Go red for women campaign” widely in China, would 
raise awareness of the urgent situation of CVD in women. Also, development of 
tailored, cultural, economic interventions of CVD risk factors will require more 
women participation in research programs. 
-----------------Insert Figure 3 here------------ 
 
Implications for nursing practice 
CVD is already a leading cause of death and disability in Chinese women.  
Awareness-raising and education is the first key to reduction of CVD. Like other 
eastern countries, women often defer their own needs in favor of the needs of others, 
namely their families. Lower perceived susceptibility, higher perceived benefit of 
Chinese herbs and lower perceived benefit of Western medications are also barriers to 
changing the CVD burden60. Bearing these Chinese cultural factors in nurses’ minds, 
the effort of such education programs should be targeted at the general public, other 
healthcare providers, and women, especially those with CVD risk factors. The 
structured health education program by a diabetic nurse has shown significant 
improvements in controlling cardiovascular risk factors in Chinese Type 2 diabetic 
patients69.  This outcome indicated that regular reinforcement through an 
intervention program should be part of care provided by nurses as it represents a 
“critical moment” when women come to the clinic or hospital. 
 
Secondly, it is well known that distinct gender and ethnic differences exist in terms of 
presentation of symptoms, validity of diagnostic tests, drug side effects, and 
complications70-71. With respect to CVD risk factors, Chinese women have higher 
rates of diabetes and hypertension but are less frequently smokers. They have a higher 
incidence of stroke and less frequent coronary heart disease. In light of the paucity of 
Chinese women-specific research, it is important to undertake further nurse-lead 
research programs in order to stem a higher CVD burden. Strategies that advance the 
educational preparation of Chinese nurses to the Masters and Doctoral level will also 
likely fuel the development of culturally appropriate interventions. 
  
Conclusion 
As a consequence of rapid economic development, urbanization, and change of 
lifestyle, CVD has become the main killer of Chinese women.  Sadly, preventive and 
educational programs have not kept pace with this growth. Stroke and heart disease 
account for about 40% of the annual mortality in Chinese women, well ahead of the 
20% caused by all forms of cancer. During the past decades the incidence in most 
western countries halved, but the statistics do not follow the same downward 
trajectory for Chinese women. The main driving force is the change of lifestyle, 
including unhealthy diet, inactivity, smoking, and obesity. Given these factors are 
responsible for 75% of the incidence of CVD, strategies involving individuals, 
communities, and government authorities should be targeted as primary and 
secondary prevention against the CVD epidemic in this risk group. China has 
successfully reduced the mortality rate of childbirth, malnutrition and infectious 
disease in Chinese women. The time is coming to bridge the gap between knowledge 
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Table 1 the trend of life expectancy in China4 
Life Expectancy (Year) 
Year Data Source Total Male Female 
Before 1949 … 35.0  … … 
1957 
  70 Cities, 1 County and 126 
Townships  
  in 11 Provinces 
57.0  … … 
1973-75   Retrospective Survey on Tumor Death   in China … 63.6  66.3  
1981  The 3rd National Population Census 67.9  66.4  69.3  
1990  The 4th National Population Census 68.6  66.8  70.5  




























 Table 2 Health transition in China4           
 2000 1957 
1st Disease of the heart Disease of respiratory system 
2nd Malignant neoplasms Acute infectious disease 
3rd Cerebrovascular disease Tuberculosis 
4th Pneumonia and influenza Digestive disease 
5th Infectious disease Disease of the Heart 
6th Accidents Cerebrovascular disease 




































Table 3 Ten main causes contributed to Chinese women’s death in 20054 
Death Rate of 10 Main Diseases in Certain Region in 2005(Female)  
 
Rank 





















Diseases of the 
Respiratory System 128.53  
26.6
0  
2 Heart Disease 96.88 20.09 
Cerebrovascular 
Disease 106.11  
21.9
5  
3 Malignant Neoplasms 88.51 18.36 
Malignant  
Neoplasms 76.99  
15.9
3  
4 Diseases of the Respiratory System 61.85 
12.8
3 
Heart Disease 66.46  13.75  
5 Injury & Poisoning 33.22 6.90 Injury & Poisoning 31.36  6.49  
6 Endocrine, Nutritional  
& Metabolic Diseases 
15.77 3.27 Diseases of the  
Digestive System  
11.56  2.39  
7 Diseases of the  
Digestive System  
13.46 2.79 Endocrine, Nutritional  
& Metabolic Diseases 
7.45  1.54  
8 Disease of the Genitourinary System 8.21 1.70 
Disease of the 
Genitourinary System 6.73  1.39  
9 Mental Disorders 5.55  1.15 Mental Disorders 2.62  0.54  
10 Disease of the Nervous System 4.66 0.97 Pulmonary  Tuberculosis 1.78  0.37  























Table 4 Comparison of dietary constitution from 1982 to 20024 
 
 
Total Urban residents Rural residents 
1982 1992 2002 1982 1992 2002 1982 1992 2002 
Energy from 
cereals (%) 71.2 66.8 57.9 65.0 57.4 48.5 74.6 71.7 61.5 
Energy from 
animal (%) 7.9 9.3  12.6  12.4 15.2  17.6  4.2 6.2  10.7  
Energy from 































Figure 1 Prevalence of hypertension among Chinese women, aged 35 to 74 years, in 
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